MENU
IONS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ionis Pharmaceuticals (IONS) Ownership - Who owns Ionis Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.63B
P/E Ratio
N/A
Total Cash
2.48B
Projected Growth
N/A
Total Debt
1.45B
Revenue
803.07M
Risk (Beta)
-0.00
Dividend Yield
N/A
Total Cash/Share
15.73
Total Debt/Equity
N/A
Revenue/Share
5.50 USD as % of share price
Fundamentals
IONS
Capitalization
5.63B
P/E Ratio
N/A
Risk (Beta)
-0.00
Dividend Yield
N/A
Total Cash
2.48B
Total Cash/Share
15.73
Total Debt
1.45B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.50%
Revenue
803M
ROE
N/A
Book Value
662M
P/B Ratio
8.49
Cash Flow
N/A
Earnings
-2.44
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
158K
Current Ratio
8.91
Current Revenue Per Employee
144351.67
Dividends Per Share - Security
N/A
EBITDA
-249.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.20
Revenue To Assets
-11.93
Shares Held By Institutions
17.8B
Shares Outstanding - Current
158M
Total Liabilities
2.42B
Total Volume MTD
N/A
Value
-1
Gain YTD
-29.571
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of antisense drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com